Back

Efficacy of trimetazidine on functional capacity in symptomatic patients with moderately reduced or left ventricular dysfunction and CAD: a subgroup analysis of the VASCO trial

22 May 2016 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Drug therapy, other Drug therapy, other HFA Premium Access HEART FAILURE 2016

9 More presentations in this session

Presentation thumbnail
Doctor J. Laukaitiene (Kaunas, LT)
Abstract Slides
Presentation thumbnail
Associate Professor M. Cameli (Siena, IT)
Abstract
Presentation thumbnail
Presentation thumbnail
Doctor P. Pellicori (Glasgow, GB)
Abstract
Presentation thumbnail
Doctor N. Giannetti (Montreal, CA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Drug therapy, other

The Event

Event poster

HEART FAILURE 2016

22 May 2016 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources